National Institute on Drug Abuse Funding Opportunity

Behavioral & Integrative Treatment Development Program (R01 Clinical Trial Optional)

Funding Opportunity: PAR-22-182

Application Deadline: August 10, 2023

Purpose: The overarching goal of this FOA is to produce maximally efficacious behavioral interventions (individual and group) to treat substance abuse, promote medication/treatment adherence, and prevent HIV, and leverage new knowledge in neuroscience, new technologies and pharmacotherapies that may improve tangible outcomes of behavioral interventions (e.g., improving cognitive function). This FOA underscores the importance of fostering research aimed at boosting intervention effects to produce targeted treatments across populations (including pregnant women, individuals with comorbid psychiatric disorders, and prisoners) or populations with pain.

For more information, please see the announcement website.